Key result
Elevated baseline levels of brain natriuretic peptide (HR 1.695) and blood urea nitrogen, along with lower systolic blood pressure, were independently associated with increased 1-year mortality in patients with chronic systolic heart failure.
Why the study?
Understanding population-specific determinants of heart failure outcomes remains a challenge, prompting evaluation of predictors of 1-year survival in patients with systolic heart failure in Brazil.
Cohort (n=695)
No
In a Brazilian cohort of patients with chronic systolic heart failure, elevated blood urea nitrogen and brain natriuretic peptide, along with lower systolic blood pressure, were independent predictors of 1-year mortality.
BACKGROUND: Heart failure (HF) is a major public health problem with increasing prevalence worldwide. It is associated with high mortality and poor quality of life due to recurrent and costly hospital admissions. Several studies have been conducted to describe HF risk predictors in different races, countries and health systems. Nonetheless, understanding population-specific determinants of HF outcomes remains a great challenge. We aim to evaluate predictors of 1-year survival of individuals with systolic heart failure from the GENIUS-HF cohort. METHODS: We enrolled 700 consecutive patients with systolic heart failure from the SPA outpatient clinic of the Heart Institute, a tertiary health-center in Sao Paulo, Brazil. Inclusion criteria were age between 18 and 80 years old with heart failure diagnosis of different etiologies and left ventricular ejection fraction ≤50% in the previous 2 years of enrollment on the cohort. We recorded baseline demographic and clinical characteristics and followed-up patients at 6 months intervals by telephone interview. Study data were collected and data quality assurance by the Research Electronic Data Capture tools. Time to death was studied using Cox proportional hazards models adjusted for demographic, clinical and socioeconomic variables and medication use. RESULTS: We screened 2314 consecutive patients for eligibility and enrolled 700 participants. The overall mortality was 6.8% (47 patients); the composite outcome of death and hospitalization was 17.7% (123 patients) and 1% (7 patients) have been submitted to heart transplantation after one year of enrollment. After multivariate adjustment, baseline values of blood urea nitrogen (HR 1.017; CI 95% 1.008-1.027; p < 0.001), brain natriuretic peptide (HR 1.695; CI 95% 1.347-2.134; p < 0.001) and systolic blood pressure (HR 0.982;CI 95% 0.969-0.995; p = 0.008) were independently associated with death within 1 year. Kaplan Meier curves showed that ischemic patients have worse survival free of death and hospitalization compared to other etiologies. CONCLUSIONS: High levels of BUN and BNP and low systolic blood pressure were independent predictors of one-year overall mortality in our sample. TRIAL REGISTRATION: Current Controlled Trials NTC02043431, retrospectively registered at in January 23, 2014.
No takes yet. Share an insight, caveat, or question.
Gioli‐Pereira et al. (2019) conducted a cohort in Chronic systolic heart failure (n=695). Elevated brain natriuretic peptide (Log BNP) was evaluated on All-cause mortality at 1 year (HR 1.695, 95% CI 1.347-2.134, p=<0.001). Elevated baseline levels of brain natriuretic peptide (HR 1.695) and blood urea nitrogen, along with lower systolic blood pressure, were independently associated with increased 1-year mortality in patients with chronic systolic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: